Shalini Sharp - Net Worth and Insider Trading
Shalini Sharp Net Worth
The estimated net worth of Shalini Sharp is at least $6 Million dollars as of 2024-09-20. Shalini Sharp is the EVP, Finance of Ultragenyx Pharmaceutical Inc and owns about 97,812 shares of Ultragenyx Pharmaceutical Inc (RARE) stock worth over $6 Million. Shalini Sharp is the Director of Neurocrine Biosciences Inc and owns about 994 shares of Neurocrine Biosciences Inc (NBIX) stock worth over $119,737. Shalini Sharp is also the Director of Agenus Inc and owns about 4,066 shares of Agenus Inc (AGEN) stock worth over $24,274. Details can be seen in Shalini Sharp's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Shalini Sharp has not made any transactions after 2024-05-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Shalini Sharp
Shalini Sharp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Shalini Sharp owns 9 companies in total, including Ultragenyx Pharmaceutical Inc (RARE) , Panacea Acquisition Corp (PANA.U) , and Sutro Biopharma Inc (STRO) among others .
Click here to see the complete history of Shalini Sharp’s form 4 insider trades.
Insider Ownership Summary of Shalini Sharp
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
RARE | Ultragenyx Pharmaceutical Inc | 2020-10-14 | CFO & Senior Vice President |
PANA.U | Panacea Acquisition Corp | 2020-06-30 | director |
STRO | Sutro Biopharma Inc | 2018-11-08 | director |
2019-03-27 | director | ||
2024-05-17 | director | ||
2016-09-16 | director | ||
2021-03-26 | director | ||
2020-06-30 | director | ||
2021-05-14 | director |
Shalini Sharp Latest Holdings Summary
Shalini Sharp currently owns a total of 3 stocks. Among these stocks, Shalini Sharp owns 97,812 shares of Ultragenyx Pharmaceutical Inc (RARE) as of October 14, 2020, with a value of $6 Million and a weighting of 97.56%. Shalini Sharp owns 994 shares of Neurocrine Biosciences Inc (NBIX) as of May 17, 2024, with a value of $119,737 and a weighting of 2.03%. Shalini Sharp also owns 4,066 shares of Agenus Inc (AGEN) as of January 30, 2013, with a value of $24,274 and a weighting of 0.41%.
Latest Holdings of Shalini Sharp
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
RARE | Ultragenyx Pharmaceutical Inc | 2020-10-14 | 97,812 | 58.77 | 5,748,411 |
NBIX | Neurocrine Biosciences Inc | 2024-05-17 | 994 | 120.46 | 119,737 |
AGEN | Agenus Inc | 2013-01-30 | 4,066 | 5.97 | 24,274 |
Holding Weightings of Shalini Sharp
Shalini Sharp Form 4 Trading Tracker
According to the SEC Form 4 filings, Shalini Sharp has made a total of 4 transactions in Ultragenyx Pharmaceutical Inc (RARE) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Ultragenyx Pharmaceutical Inc is the sale of 375 shares on October 14, 2020, which brought Shalini Sharp around $32,996.
According to the SEC Form 4 filings, Shalini Sharp has made a total of 1 transactions in Neurocrine Biosciences Inc (NBIX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Neurocrine Biosciences Inc is the sale of 1,106 shares on May 17, 2024, which brought Shalini Sharp around $156,941.
According to the SEC Form 4 filings, Shalini Sharp has made a total of 0 transactions in Agenus Inc (AGEN) over the past 5 years. The most-recent trade in Agenus Inc is the sale of 14 shares on January 30, 2013, which brought Shalini Sharp around $1,256.
Insider Trading History of Shalini Sharp
- 1
Shalini Sharp Trading Performance
Shalini Sharp Ownership Network
Shalini Sharp Owned Company Details
What does Ultragenyx Pharmaceutical Inc do?
Who are the key executives at Ultragenyx Pharmaceutical Inc?
Shalini Sharp is the CFO & Senior Vice President of Ultragenyx Pharmaceutical Inc. Other key executives at Ultragenyx Pharmaceutical Inc include Controller and PAO Theodore Alan Huizenga , director & 10 percent owner & President & CEO Emil D Kakkis , and EVP and General Counsel Karah Herdman Parschauer .
Ultragenyx Pharmaceutical Inc (RARE) Insider Trades Summary
Over the past 18 months, Shalini Sharp made no insider transaction in Ultragenyx Pharmaceutical Inc (RARE). Other recent insider transactions involving Ultragenyx Pharmaceutical Inc (RARE) include a net sale of 147,853 shares made by Emil D Kakkis , a net sale of 4,391 shares made by Sanders Corazon (corsee) D. , and a net sale of 3,565 shares made by Theodore Alan Huizenga .
In summary, during the past 3 months, insiders sold 40,675 shares of Ultragenyx Pharmaceutical Inc (RARE) in total and bought 0 shares, with a net sale of 40,675 shares. During the past 18 months, 257,334 shares of Ultragenyx Pharmaceutical Inc (RARE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 257,334 shares.
Ultragenyx Pharmaceutical Inc (RARE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ultragenyx Pharmaceutical Inc Insider Transactions
Shalini Sharp Mailing Address
Above is the net worth, insider trading, and ownership report for Shalini Sharp. You might contact Shalini Sharp via mailing address: C/o Ultragenyx Pharmaceutical Inc., 60 Leveroni Court, Novato Ca 94949.